KRMD Earnings Prediction
The chart below shows how KRMD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, KRMD sees a +2.94% change in stock price 10 days leading up to the earnings, and a -0.61% change 10 days following the report. On the earnings day itself, the stock moves by +0.06%. This data can give you a slight idea of what to expect for the next quarter's release.
KRMD Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
8.18M
16.80%
-2.97%
Gross Margin
60.61%
2.87%
-2.90%
Operating Margin
-20.82%
-18.58%
47.24%
Net Margin
-19.33%
-1.07%
64.79%
EPS
-0.03
-0.00%
50.00%
No Data Available
KRMD Earnings Analysis
KORU Medical Systems, Inc. Common Stock (DE) Corporation (KRMD.O) Earnings Conference Call
Positive
Consistent Revenue Increase: 1. Strong Revenue Growth: KORU Medical Systems reported third quarter revenues of $8.2 million, reflecting a 17% increase year-over-year and marking the third consecutive quarter of double-digit revenue growth.
Gross Profit Improvement: 2. Improved Gross Profit: The company achieved a gross profit growth of 19% year-over-year, with gross margin improving by 140 basis points to 63.4%.
International Segment Expansion: 3. Significant International Growth: The international segment experienced a 38% year-to-date growth, with quarterly revenue of $1.1 million, driven by strong performance in new geographies and consumable growth.
Novel Therapies Revenue Growth: 4. Novel Therapies Surge: Revenues from Novel Therapies reached $600,000, representing a remarkable 276% growth year-over-year, attributed to increased collaborations and clinical trial orders.
Cash Balance Improvement: 5. Strong Cash Position: KORU ended the quarter with a cash balance of $8.8 million, reflecting a 60% reduction in year-to-date cash usage compared to the same period in 2023.
Negative
Product Submission Delay: 1. Delayed Product Submission: The anticipated 510(k) submission for the next-generation device has been pushed from Q4 2024 to mid-2025, potentially impacting the timing of product launches.
Cash Burn Analysis: 2. Increased Cash Burn: The company reported a cash usage of $1.7 million in Q3 2024, which included a net loss of $800,000 and $700,000 in capital expenditures, indicating ongoing financial strain despite a reduction in year-to-date cash usage.
Inventory Management Challenges: 3. Inventory Growth: The company experienced a $200,000 increase in cash usage from working capital due to higher inventory levels, which were strategically increased in anticipation of supply chain disruptions, suggesting potential inefficiencies in inventory management.
Operating Expense Projection: 4. Operating Expense Increase: The projected operating expenses for the year have been raised to a range of $24.5 million to $25 million, up from the previous guidance of $23.5 million to $24 million, indicating rising costs that could pressure profitability.
International Revenue Performance: 5. International Growth Normalization: International revenue growth was reported at 5% for the quarter, but without the effects of prior excess inventory, normalized growth would have been approximately 25%, highlighting potential volatility in international sales performance.
KRMD FAQs
How does KRMD typically perform around its earnings report dates?
Is KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
KRMD Earning Call Sentiment
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
KRMD.O
0%Positive
The earnings call shows strong financial performance with revenue growth, increased guidance, and improved margins. Despite inflationary pressures, the company maintains a robust cash position and plans for international expansion. The Q&A reveals confidence in product launches and partnerships. While there are concerns about delays and vague future projections, the overall sentiment is positive, particularly with the raised revenue and margin guidance. Considering these factors, the stock price is likely to see a positive movement in the short term.
